3BG-23401-65126
4 vaccinations
10 coded responses
29 check-ins
10 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 038 / NH
- Registered
- 2021-05-29
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
ZE5-20187-68032
Child or adolescent in my care · Female · 2021-06-26
Timeline
-
2021-03-22
Dose 1 — Moderna
-
2021-04-19
Dose 2 — Moderna
-
2021-05-29
Registered in v-safe
- 2021-05-29
- 2021-05-31
-
2021-07-19
Survey response — 3 months, dose 2MedDRA: Fatigue, Headache, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Extra pain, headaches and fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2021-07-19
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-27
- 2021-07-30
-
2021-10-18
Survey response — 6 months, dose 2MedDRA: Hepatic enzyme increased, Neuropathy peripheral, Surgery, Thoracic outlet syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Neuropathy associated with thoracic outlet syndrome post surgery. Increase in liver enzymesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-18
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-10-20
- 2021-10-23
-
2021-12-15
Dose 3 — Pfizer-BioNTech
-
2021-12-18
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Dizziness, moderateMedDRA releases: 2024-11 · check-in free text available
-
2021-12-19
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Fair · Muscle or body achesFree text: Dizziness, mildMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Dizziness, mildMedDRA releases: 2024-11 · check-in free text available
-
2021-12-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-22
- 2021-12-29
- 2022-01-07
-
2022-01-12
Survey response — day 28, dose 3MedDRA: Cough, Fatigue, Insomnia, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Continuing cough, sore throat and congestion with extreme fatigue and insomniaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-13
- 2022-01-18
- 2022-01-19
-
2022-01-28
Survey response — day 42, dose 3MedDRA: Diarrhoea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Constant DiahhreaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-02-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-02-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-02-01
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-03-16
- 2022-06-17
-
2022-10-14
Dose 4 — Pfizer-BioNTech
-
2022-10-15
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Dizzy/lightheadednessMedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body achesAdult check-in
- 2022-10-17
-
2022-10-18
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-19
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Headache, Muscle or body achesFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Health check-in — day 7, dose 4Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2022-10-28
Survey response — day 14, dose 4MedDRA: Arthralgia, Diaphragmalgia, Menstrual disorder, Migraine, Myalgia, Pain, Pelvic pain — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Pain throughout my body including joints, muscles, diaphragm, and pelvic pain. Abnormal menstrual bleeding and migration headaches.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Report sent to call center — day 14, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-31
Call successfulParticipant prefers to complete VAERS report online
- 2022-11-04
- 2022-11-13
- 2022-11-18
- 2022-11-25
- 2023-01-13
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Moderna | |
| 2 | 2021-04-19 | Moderna | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
| 4 | 2022-10-14 | Pfizer-BioNTech | No |
Call center
5 call center cases
5 successful
Free text
Release 9 — 3 months, dose 2
Symptoms: Extra pain, headaches and fatigue.
Release 10 — 6 months, dose 2
Symptoms: Neuropathy associated with thoracic outlet syndrome post surgery. Increase in liver enzymes
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Dizziness, moderate
Systemic reaction (other): Dizziness, mild
Systemic reaction (other): Dizziness, mild
Release 10 — day 28, dose 3
Symptoms: Continuing cough, sore throat and congestion with extreme fatigue and insomnia
Release 11 — day 42, dose 3
Symptoms: Constant Diahhrea
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Dizzy/lightheadedness
Systemic reaction (other): Sore throat
Release 12 — day 14, dose 4
Symptoms: Pain throughout my body including joints, muscles, diaphragm, and pelvic pain. Abnormal menstrual bleeding and migration headaches.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diaphragmalgia | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hepatic enzyme increased | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pelvic pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Surgery | · | · | ✓ |
| SD | Thoracic outlet syndrome | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release